Department of Ultrasound, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, 212002, PR China.
Institute of Ultrasound Imaging and Department of Ultrasound, Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, PR China.
Biomaterials. 2017 Oct;142:13-30. doi: 10.1016/j.biomaterials.2017.07.016. Epub 2017 Jul 11.
The clinical ultrasound (US)-based theranostic biomedicine suffers from the critical issue that traditional microbubbles (MBs) have lots of drawbacks such as low stability, large particle size, difficult structural control, etc. The unique composition, structure and functionality of inorganic micro/nanoplatforms have shown their great prospect for solving these critical issues and drawbacks of traditional organic MBs. This review summarizes and discusses the state-of-art development on exploring inorganic micro/nanoparticles for versatile US-based biomedical applications, ranging from US imaging, photoacoustic imaging, sonodynamic therapy, high intensity-focused US ablation and US-triggered chemotherapy. These inorganic micro/nanoplatforms include silica-based particles, Au, carbon nanotubes, TiO, manganese oxide, iron oxide, Prussian blue, inorganic gas-generating nanoparticles and their versatile composite micro/nanosystems. Especially, their unique structure/composition-functionality relationships and biocompatibility/biosafety in US-based theranostics have been discussed and revealed in detail. Their facing challenges and future developments are finally discussed to promote their further clinical translations. It is highly expected that these inorganic micro/nanoplatforms will enter the clinical stage to benefit the personalized theranostics biomedicine based on their unique functionalities and high performance as necessarily required in US-based theranostics.
临床超声(US)基治疗诊断生物医学受到传统微泡(MBs)存在许多缺点的严重问题的困扰,例如低稳定性、大粒径、结构控制困难等。无机微/纳平台的独特组成、结构和功能为解决传统有机 MBs 的这些关键问题和缺点展示了广阔的前景。本综述总结和讨论了探索用于各种基于 US 的生物医学应用的无机微/纳颗粒的最新进展,涵盖了 US 成像、光声成像、声动力学治疗、高强度聚焦 US 消融和 US 触发化疗。这些无机微/纳平台包括基于硅的颗粒、金、碳纳米管、TiO、氧化锰、氧化铁、普鲁士蓝、无机产气纳米颗粒及其多功能复合微/纳系统。特别是,详细讨论和揭示了它们独特的结构/组成-功能关系以及基于 US 的治疗诊断中的生物相容性/生物安全性。最后讨论了它们面临的挑战和未来的发展,以促进它们在基于 US 的治疗诊断中的进一步临床转化。这些无机微/纳平台有望进入临床阶段,基于其独特的功能和基于 US 的治疗诊断所需的高性能,为基于个性化的治疗诊断生物医学带来益处。